Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Retinoids help manage skin conditions in black individuals.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Autologous Regenerative Therapy may improve hair restoration by using stem cells from fat.

Combining different treatments may be needed to effectively manage chronic prostatitis.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Alitretinoin may help treat alopecia areata.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

New treatments for severe alopecia areata show promise but lack standard approval.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

New psoriasis treatments are effective but come with side effects and risks.